US EditionHigh Hepatitis C Cure Rate After Retreatment in People Who Inject Drugs
Summary by European Medical Journal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
NS3 of Hepatitis C Virus Drives Hepatocellular Carcinoma Progression through a Novel RNA-Interference Pathway
Researchers employed transcriptome sequencing to explore the role of non-structural protein 3 (NS3) in promoting HCC progression by comparing gene expression profiles between hepatitis C virus-infected HCC tissues and healthy liver controls. [Journal of Cell Communication and Signaling] Full Article
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
